| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.095 | 0.03 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | 0.24 | 0.03 |
| mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.03 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | 0.36 | 0.03 |
| mRNA | Imatinib | FIMM | pan-cancer | AAC | 0.37 | 0.03 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.11 | 0.03 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.11 | 0.03 |
| mRNA | KIN001-135 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | CGP-60474 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.03 |